针对先天性代谢缺陷市场的医疗食品基于(关键地区、市场参与者、规模和份额)- 到 2031 年的预测

  • Report Code : TIPRE00011389
  • Category : Pharmaceuticals
  • Status : Published
  • No. of Pages : 243
Buy Now

2019年先天性代谢缺陷医疗食品市场价值为25.078亿美元,预计2027年将达到57.6879亿美元;预计2020年至2027年复合年增长率为11.2%。

医疗食品是指在医生监督下配制的专门食品,旨在针对特定疾病进行特定饮食管理或条件。这些医疗状况通常具有基于医学评估建立的科学和公认原则的独特营养要求。药用食品与药物不同;然而,它们旨在作为主要干预措施在医疗监督下消费。当婴儿被诊断患有先天性新陈代谢缺陷时,通常会为他们开出适合其特定状况的特殊饮食,并且必须终生遵循。全球先天性代谢缺陷医疗食品市场的增长归因于先天性代谢缺陷发病率的增加以及对膳食补充剂的偏好增加。然而,先天性代谢缺陷医疗食品的局限性是阻碍市场增长的主要因素。

全球先天性代谢缺陷医疗食品市场预计将增长见证大流行后的大幅增长。由于封锁、旅行禁令和企业关闭,COVID-19 已经影响了各国的经济和行业。 COVID-19 危机使许多国家的公共卫生系统负担过重,凸显了对卫生系统可持续投资的强烈需求。随着 COVID-19 大流行的进展,医疗保健行业的增长预计将下降。由于体外诊断产品需求的增加以及全球研发活动的增加,生命科学领域蓬勃发展。然而,由于进行的手术数量减少以及设备采购推迟或延长,医疗技术和成像领域的销售额正在下降。此外,医疗保健专业人员的虚拟咨询预计将成为大流行后的主流护理服务模式。随着远程医疗改变医疗服务方式,数字医疗将在未来几年继续蓬勃发展。此外,临床试验的中断以及随后药物上市的延迟预计也将为未来的完全虚拟试验铺平道路。 mRNA 等新技术预计将出现并改变制药行业,未来几年市场预计还将出现更多的垂直整合和合资企业。

全球先天性代谢缺陷医疗食品市场利润丰厚的地区


 < /p>

市场洞察

对膳食补充剂的偏好日益增长,推动全球医疗食品治疗先天性代谢缺陷市场的增长

营养补充剂和处方医疗食品的消费率与基于酶的治疗药物相比正在增加。医疗保健成本的不断增加以及消费者对简单有效的疾病管理疗法的日益偏好可能是导致从药物向医疗补充剂和营养食品转变的原因。医疗食品是指用于治疗包括先天性代谢缺陷在内的各种疾病的饮食管理的一类产品,其中含有特定的营养素,以满足患有特定病症的患者的营养需求。

美国食品和药物管理局美国食品和药物管理局 (FDA) 将医疗食品分为代谢紊乱配方、完全营养产品、不完全营养产品和口服补液溶液四大类。

医疗食品很容易获取,因为它们本身就很容易获得。不需要处方,但必须在医疗监督下服用。如果患有先天性代谢缺陷,可以使用医疗食品作为治疗选择,并且市场上出售的产品受到权威和监管食品和膳食补充剂状态的监管。先天性代谢缺陷的营养治疗可为患有特定遗传性疾病的人提供 85% 至 90% 的营养需求。此外,这些补充剂的副作用几乎可以忽略不计,非常适合所有年龄段的患者食用。近年来,美国和其他一些国家的私人医疗保险公司也为某些医疗食品的消费提供报销计划。因此,医疗食品和营养补充剂的日益普及预计将在未来几年促进市场增长。

基于产品的见解

从产品类型来看,全球先天性代谢缺陷医疗食品市场细分为氨基酸、GMP甘肽、氨基酸改良含铁婴儿配方奶粉、低钙/维生素D含铁婴儿配方奶粉、低蛋白食品和别的。 2019年,氨基酸领域占据最大的市场份额。此外,预计同一细分市场在预测期内的复合年增长率最高。

全球先天性代谢缺陷医疗食品市场(按产品)– 2019年和2027年


基于年龄组的洞察

就年龄组而言,全球针对先天性代谢缺陷的医疗食品市场分为婴儿、断奶者、青少年和成人。 2019年,婴儿细分市场占据最大市场份额。此外,预计同一细分市场在预测期内的复合年增长率最高。

基于疾病的见解

基于疾病,全球先天性代谢缺陷市场的医疗食品分为苯丙酮尿症(PKU)、枫糖浆尿病(MSUD)、同型半胱氨酸尿症、尿素循环障碍、甲基甜瓜学术界、有机酸脲类、丙酸学术界、异戊酸学术界、亮氨酸代谢障碍、戊二酸学术界类型-1,肾脏疾病,酪氨酸血症I型和II型等。苯丙酮尿症细分市场在 2019 年占据最大的市场份额。然而,学术界 1 型戊二酸细分市场预计在未来几年将以最快的速度增长。

基于形式的见解

基于形式,全球先天性代谢缺陷医疗食品市场分为粉末、液体、凝胶、和别的。粉末细分市场在 2019 年占据了最大的市场份额。此外,预计该细分市场在预测期内将以最高的复合年增长率增长。

基于包装的见解< /h3>

就包装而言,全球治疗先天性代谢缺陷的医疗食品市场分为罐装、罐装、袋装、瓶装等。罐头细分市场在 2019 年占据了最大的市场份额。然而,包装细分市场预计在预测期内将以最高复合年增长率增长。

分销渠道 -基于洞察

从分销渠道来看,全球先天性代谢缺陷医疗食品市场分为零售药房、医院药房、网上药房、药店等。零售药店细分市场在 2019 年占据最大市场份额。此外,预计该细分市场在预测期内将以最快的速度增长。

战略见解

全球针对先天性代谢缺陷的医疗食品市场参与者正在采取产品推出和扩张策略,以满足全球不断变化的客户需求,这也使他们能够在全球范围内保持其品牌声誉。

< p> 

全球先天性代谢缺陷医疗食品市场 –副产品

  • 氨基酸
  • 符合 GMP 的 Glytactin
  • 含铁氨基酸改良婴儿配方奶粉
  • 低钙/不含维生素 D 的含铁婴儿配方奶粉
  • 低蛋白食品
  • 其他

全球先天性代谢缺陷医疗食品市场 –按年龄组

  • 婴儿
  • 断奶
  • 青少年
  • 成人  

全球先天性代谢缺陷医疗食品市场 –按疾病分类

  • 苯丙酮尿症(PKU)
  • 枫糖浆尿病(MSUD)
  • 同型半胱氨酸尿症
  • 尿素循环障碍
  • li>
  • 甲基丙二酸血症
  • 有机酸尿症
  • 丙酸血症
  • 异戊酸血症
  • 亮氨酸代谢紊乱
  • < li>I 型戊二酸血症
  • 肾脏疾病
  • I 型和 II 型酪氨酸血症
  • 其他

全球医疗食品新陈代谢市场的先天性错误 –按剂型

  • 粉末
  • 液体
  • 凝胶
  • 其他

全球医疗代谢市场先天性缺陷食品 –按包装

  • 罐装
  • 罐装
  • 小包
  • 瓶子
  • 其他

全球先天性代谢缺陷医疗食品市场 –按分销渠道划分

  • 零售药房
  • 医院药房
  • 网上药房
  • 药店
  • 其他< /li>

全球先天性代谢缺陷医疗食品市场 –按地理位置

  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • < li>欧洲
    • 法国
    • 德国
    • 意大利
    • 英国
    • 西班牙
    • 休息欧洲
  • 亚太地区 (APAC)
    • 中国
    • 印度
    • 韩国
    • 日本
    • 澳大利亚
    • 亚太地区其他地区
  • 中东和非洲非洲 (MEA)
    • 南非
    • 沙特阿拉伯
    • 阿联酋
    • 中东和非洲其他地区
  • 南美洲和中美洲 (SCAM)
    • 巴西
    • 阿根廷
    • 其他 SCAM
  • < /ul>

    公司简介

    • 雀巢健康科学
    • 雅培
    • Reckitt Benckiser Group Plc
    • Ajinomoto Cambrooke, Inc.
    • Solace Nutrition
    • Primus Pharmaceuticals, Inc.
    • BioMarin Pharmaceutical
    • 达能 SA
    • Galen Limited
    • PKU-MDmil
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


What are medical foods for inborn errors of metabolism?

Medical food refers to the specialized kind of food formulated to be consumed under physician supervision and intended for specific dietary management of a particular disease or condition. These medical conditions usually have distinctive nutritional requirements based on scientific and recognized principles that are established by medical evaluation. The medical food differs from drugs; however they are intended for consumption under the medical supervision as a primary intervention. When infants are identified with inborn errors of metabolism, they are usually prescribed a special diet suitable to their particular condition that must be followed for the lifetime.

What are the driving factors for the medical foods for inborn errors of metabolism market across the globe?

Factors such as increasing incidence of inborn errors of metabolism and increasing preference towards dietary food supplements are expected to boost the growth of the global medical foods for inborn errors of metabolism market. However, the market is likely to get impacted by the limitations associated to medical foods for inborn errors of metabolism during the forecast period.

What is the regional analysis in terms of medical foods for inborn errors of metabolism market?

North America is the largest market for the medical foods for inborn errors of metabolism market. The factors that are responsible for the dominance of the region include rising government support well-developed healthcare facilities, presence of top market players, increasing number of patients with inborn errors of metabolism and rising awareness regarding benefits of consuming nutritional supplements under medical supervision. Similarly, in Canada, increasing government initiatives to raise awareness regarding rare genetic disorders and well-established healthcare infrastructure are leading to market growth. Asia-Pacific is anticipated to register as the fastest-growing region in the global medical foods for inborn errors of metabolism market. The growth of the market is expected to be fastest in countries such as China, India, and Japan. The factors that are expected to drive the market growth include large number of patients suffering with genetic diseases and increasing launch of innovative products by local players in the Asian countries. Increasing collaborations and partnerships are also responsible for the growth of the market in the Asian region.

The List of Companies - Medical Foods for Inborn Errors of Metabolism Market 

  1. Nestlé Health Science
  2. Nutricia
  3. Solace Nutrition
  4. Abbott
  5. Mead Johnson and Company, LLC.
  6. BioMarin Pharmaceutical
  7. Ajinomoto Cambrooke, Inc.
  8. Poa Pharma
  9. PKU-MDmil
  10. Primus Pharmaceuticals, Inc.

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports